NUR 2502 Multidimensional Care III Final Exam 2026/2027 | 25+ Medication Q&A | High-Alert Drugs, Anticoagulants, Analgesics & OB Meds | Rasmussen University

This NUR 2502 Multidimensional Care III (MDC 3) Final Exam study guide (2026/2027) contains over 25 focused medication-based questions and answers covering high-alert drugs, pharmacologic classifications, purposes, black box warnings, and common adverse effects. The document emphasizes safe medication administration and nursing implications for analgesics, anticoagulants, antihypertensives, antiemetics, opioids, oxytocics, and obstetric-related medications. Key medications reviewed include Naproxen, Acetaminophen, Ketorolac, Morphine, Naloxone, Heparin, Enoxaparin, Oxytocin, Labetalol, Ondansetron, Diphenhydramine, Docusate Sodium, and prenatal vitamins. High-alert medications such as Heparin, Enoxaparin, Morphine, Oxytocin, and Labetalol are clearly identified, along with critical safety concerns including respiratory depression, GI bleeding, hepatotoxicity, epidural/spinal anesthesia risks, hypotension, and opioid withdrawal. The guide reinforces black box warnings, monitoring parameters (respiratory rate, blood pressure, bleeding risk), and priority nursing assessments. The structured Q&A format supports medication safety, exam readiness, and NCLEX-style critical thinking. Content aligns with core nursing pharmacology principles commonly taught in Rasmussen University’s Multidimensional Care III course and standard nursing pharmacology textbooks. This document is especially relevant for: • Nursing students enrolled in NUR 2502 Multidimensional Care III • Rasmussen University ADN and BSN nursing students • Students preparing for final pharmacology exams • Nursing students reviewing high-alert medications and medication safety • NCLEX preparation focused on medication administration and adverse effects Keywords: pharmacology final exam, high alert medications, anticoagulants, heparin, enoxaparin, opioid analgesics, morphine, naloxone, NSAIDs, ketorolac, naproxen, acetaminophen hepatotoxicity, oxytocin, labetalol, antihypertensives, antiemetics, ondansetron, diphenhydramine, medication safety, black box warning